Tandem Diabetes Care, Inc.
TNDM
$14.36
$0.362.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.05% | -205.64% | 102.52% | 29.46% | 13.87% |
| Total Depreciation and Amortization | 6.30% | 6.63% | 5.31% | 4.67% | -3.68% |
| Total Amortization of Deferred Charges | 6.90% | -22.31% | 1.83% | -28.49% | -14.03% |
| Total Other Non-Cash Items | -1.97% | 350.88% | 7.36% | 35.31% | -26.17% |
| Change in Net Operating Assets | 207.94% | -218.56% | -180.43% | 153.05% | 44.35% |
| Cash from Operations | -80.02% | -128.59% | 248.52% | 48,589.09% | 16.57% |
| Capital Expenditure | 4.02% | 33.48% | 40.97% | 2.98% | 12.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,098.77% | 2,128.55% | 170.96% | 66.01% | -77.62% |
| Cash from Investing | 1,742.09% | 281.69% | 130.21% | 59.00% | -162.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -12.04% | -- | -- |
| Repurchase of Common Stock | -- | 85.12% | -- | -145.60% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -1,222.88% | -134.51% | -12.04% | -136.47% | -176.04% |
| Foreign Exchange rate Adjustments | 202.24% | -344.44% | 392.27% | -34.65% | 260.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 193.41% | -14,208.11% | 197.36% | 102.62% | -477.45% |